Digital clubbing may be an indicator of systemic atherosclerosis even at microvascular level

HealthMED

Volumn 6, Issue 12, 2012, Pages 3977-3981

  Helvaci, Mehmet Rami ^a   Aydin, Leyla Yilmaz ^b   Aydin, Yusuf ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b DUZCE UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; Clubbing; Smoking

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUBBING FINGERS; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84872941041     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Myers KA, Farquhar DR. The rational clinical exami-nation. Does this patient have clubbing? JAMA 2001; 286: 341-347.
2. Schamroth L. Personal experience. S Afr Med J 1976; 50: 297-300.
3. Sridhar KS, Lobo CF, Altman RD. Digital clubbing and lung cancer. Chest 1998; 114: 1535-1537.
4. Epstein O, Dick R, Sherlock S. Prospective study of periostitis and finger clubbing in primary biliary cirr-hosis and other forms of chronic liver disease. Gut 1981; 22: 203-206.
5. Naeije R. Hepatopulmonary syndrome and portopulmo-nary hypertension. Swiss Med Wkly 2003; 133: 163-169.
6. Goodyer MJ, Cronin MC, Ketsitlile DG, O'Reilly SP, Moylan EJ, Maher MM, et al. Hodgkin's lymphoma with digital clubbing. J Clin Oncol 2009; 27: 95-96.
7. Dever LL, Matta JS. Digital clubbing in HIV-infected patients: an observational study. AIDS Patient Care STDS 2009; 23: 19-22.
8. Mathur SK, Sharma BB, Choudhary D, Rao RS, Shi-bin TS, Singh V. Clubbing in a case of hypothyroidism. J Assoc Physicians India 2008; 56: 241.
9. Ddungu H, Johnson JL, Smieja M, Mayanja-Kizza H. Digital clubbing in tuberculosis--relationship to HIV infection, extent of disease and hypoalbuminemia. BMC Infect Dis 2006; 6: 45.
10. Vandemergel X, Renneboog B. Prevalence, aetiolo-gies and significance of clubbing in a department of general internal medicine. Eur J Intern Med 2008; 19: 325-329.
11. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Eva-luation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Cir-culation 2002; 17:106: 3143-3421.
12. American Diabetes Association. Clinical practice recommendations 1998: screening for type 2 diabe-tes. Diabetes Care 1998; 21: 1-98.
13. Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, et al. Mutations in 15-hydroxyprosta-glandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008; 40: 789-793.
14. Toovey OT, Eisenhauer HJ. A new hypothesis on the mechanism of digital clubbing secondary to pulmo-nary pathologies. Med Hypotheses 2010; 75: 511-513.
15. Alam MT, Sheikh SS, Aziz S, Masroor M. An unusual side effect of interferon alfa 2A: digital clubbing. J Ayub Med Coll Abbottabad 2008; 20: 165-166.
16. Fomin VV, Popova EN, Burnevich EZ, Kuznetsova AV. Hippocratic fingers: clinical importance and differen-tial diagnosis. Klin Med (Mosk) 2007; 85: 64-68.
17. Ferrari R, Tanni SE, Lucheta PA, Faganello MM, do Amaral RA, Godoy I. Gender differences in predic-tors of health status in patients with COPD. J Bras Pneumol 2010; 36: 37-43.
18. del Puerto-Nevado L, Pérez-Rial S, Girón-Martínez A, Peces-Barba G. Role of inflammation in the etiopatho-genesis of COPD. Arch Bronconeumol 2010; 46: 2-7.
19. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998; 279: 1477-1482.
20. Mannino DM, Watt G, Hole D, Gillis C, Hart C, McConnachie A, et al. The natural history of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 627-643.
21. Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization. Arch Intern Med 2000; 160: 2653-2658.
22. Anthonisen NR, Connett JE, Enright PL, Manfreda J; Lung Health Study Research Group. Hospitaliza-tions and mortality in the Lung Health Study. Am J Respir Crit Care Med 2002; 166: 333-339.
23. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA; TORCH Clinical Endpoint Committee. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Com-mittee. Thorax 2007; 62: 411-415.
24. Jemal A, Ward E, Hao Y, Thun M. Trends in the le-ading causes of death in the United States, 1970-2002. JAMA 2005; 294: 1255-1259.
25. Murray CJ, Lopez AD. Regional patterns of disabi-lity-free life expectancy and disability-adjusted life expectancy: global Burden of Disease Study. Lancet 1997; 349: 1347-1352.
26. Helvaci MR, Aydin LY, Aydin Y. Chronic obstructive pulmonary disease may be one of the terminal end points of metabolic syndrome. Pak J Med Sci 2012; 28: 376-379.